Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
Code
        if ($this->_init && !is_writable($this->settings['path'])) {
            $this->_init = false;
            trigger_error(sprintf(__('%s is not writable', true), $this->settings['path']), E_USER_WARNING);
FileEngine::__active() - CORE/cake/libs/cache/file.php, line 267
FileEngine::init() - CORE/cake/libs/cache/file.php, line 94
Cache::_buildEngine() - CORE/cake/libs/cache.php, line 151
Cache::config() - CORE/cake/libs/cache.php, line 126
include - /home/pharma/website/releases/20120317114903/cakephp/app/pharmalicensing/config/core.php, line 345
Configure::__loadBootstrap() - CORE/cake/libs/configure.php, line 391
Configure::getInstance() - CORE/cake/libs/configure.php, line 52
include - CORE/cake/bootstrap.php, line 38
[main] - /home/pharma/website/releases/20120317114903/cakephp/webroot/pharmalicensing/index.php, line 100

• Home
• Licensing Center
  • Data Center
    • Out-licensing
    • In-licensing
    • Companies
    • Services
  • Reports
  • Newsletter
    • Subscribe
    • Partnering Update
    • Key Reports
    • Pharmalicensing Recommends
  • Pharmalicensing Intelligence
    • Industry News
    • Deals Review
    • Press Releases
    • Articles
  • Profiled Companies
  • Events
• Our Services
  • Partnering Search
  • Company Profiling
  • Reports
  • Pharma Transfer
  • Deal Negotiation
  • Pharmalicensing Intelligence
• About us
  • Case Studies
  • Our Audience
  • FAQ
  • Directions
  • MedicalDeviceLicensing.com
  • Innovaro Corporate
• Contact us

Login    Register

Search

Industry news

• Industry news
• Deals and Alliances
• News

Omnicare Announces Acquisition of Continuing Care Rx

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Request a demo of
Pharmalicensing Intelligence

Company details

If you want to find out more about the company visit Omnicare profile.

Related reports

Market Research Reports provided by reports.innovaro.com

Omnicare, Inc.: SWOT Analysis & Company Profile

Sep 2010 - 25 pages - $99

Omnicare, Inc - SWOT Analysis

Jun 2010 - 23 pages - $125

Omnicare, Inc - Strategy, SWOT and Corporate Finance Report

Mar 2011 - 27 pages - $125

Omnicare, Inc - Strategy, SWOT, and Corporate Finance Report

Jun 2011 - 50 pages - $125

Omnicare, Inc. (OCR) - Financial and Strategic SWOT Analysis Review

Feb 2011 - 33 pages - $125

Omnicare, Inc. (OCR) - Financial and Strategic SWOT Analysis Review

May 2011 - 37 pages - $125

Omnicare, Inc.: Company Profile and SWOT Analysis

Sep 2011 - 39 pages - $99

Res-Care, Inc.: SWOT Analysis & Company Profile

Sep 2010 - 24 pages - $99

Life Care Centers of America: SWOT Analysis & Company Profile

Sep 2010 - 13 pages - $99

Coventry Health Care, Inc.: SWOT Analysis & Company Profile

Sep 2010 - 25 pages - $99

More Related Market Research Reports >>>

Related news

Latest News

OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary

Omnicare Announces Acquisition of Continuing Care Rx

CULS Conversion and Additional Listing

US Educational Support Service for MS Community, MS LifeLines

Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP

LGC and China Association for Standardisation sign Memorandum of Understanding

3M to Acquire Attenti Holdings S.A.

GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program

SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products

Meda acquires Alaven, a US specialty pharma company

More news... | RSS Feed...

Most Viewed

OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary

CULS Conversion and Additional Listing

Omnicare Announces Acquisition of Continuing Care Rx

US Educational Support Service for MS Community, MS LifeLines

SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products

Orphagen Pharmaceuticals Awarded Phase 2 SBIR Funding to Investigate Novel Drug Class for CNS Disorders

LGC and China Association for Standardisation sign Memorandum of Understanding

Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP

Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment

Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map

© Copyright 1998-2012 Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us